Schizophrenia Research and Treatment最新文献_第5页

Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis. 血管内皮生长因子和脑源性神经营养因子在奎硫平治疗首发精神病中的作用。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-02-05 DOI: 10.1155/2014/719395

Brendan P Murphy, Terence Y Pang, Anthony J Hannan, Tina-Marie Proffitt, Mirabel McConchie, Melissa Kerr, Connie Markulev, Colin O'Donnell, Patrick D McGorry, Gregor E Berger

{"title":"Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis.","authors":"Brendan P Murphy, Terence Y Pang, Anthony J Hannan, Tina-Marie Proffitt, Mirabel McConchie, Melissa Kerr, Connie Markulev, Colin O'Donnell, Patrick D McGorry, Gregor E Berger","doi":"10.1155/2014/719395","DOIUrl":"https://doi.org/10.1155/2014/719395","url":null,"abstract":"Objective. It has been suggested that atypical antipsychotics confer their effects via brain-derived neurotrophic factor (BDNF). We investigated the effect of quetiapine on serum levels of BDNF and vascular endothelial growth factor (VEGF) in drug-naive first-episode psychosis subjects. Methods. Fifteen patients drawn from a larger study received quetiapine treatment for twelve weeks. Baseline levels of serum BDNF and VEGF were compared to age- and sex-matched healthy controls and to levels following treatment. Linear regression analyses were performed to determine the relationship of BDNF and VEGF levels with outcome measures at baseline and week 12. Results. The mean serum BDNF level was significantly higher at week 12 compared to baseline and correlated with reductions in Brief Psychiatric Rating Scale (BPRS) and general psychopathology scores. Changes in serum VEGF levels also correlated significantly with a reduction in BPRS scores, a significant improvement in PANNS positive symptoms scores, and displayed a positive relationship with changes in BDNF levels. Conclusions. Our findings suggest that BDNF and VEGF are potential biomarkers for gauging improvement of psychotic symptoms. This suggests a novel neurotrophic-based mechanism of the drug effects of quetiapine on psychosis. This is the first report of VEGF perturbation in psychosis. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"719395"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/719395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32213387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 27

Investigation of anti-Toxocara and anti-toxoplasma antibodies in patients with schizophrenia disorder. 精神分裂症患者抗弓形虫和抗弓形虫抗体的研究。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-04-16 DOI: 10.1155/2014/230349

Shahram Khademvatan, Niloufar Khajeddin, Sakineh Izadi, Elham Yousefi

{"title":"Investigation of anti-Toxocara and anti-toxoplasma antibodies in patients with schizophrenia disorder.","authors":"Shahram Khademvatan, Niloufar Khajeddin, Sakineh Izadi, Elham Yousefi","doi":"10.1155/2014/230349","DOIUrl":"https://doi.org/10.1155/2014/230349","url":null,"abstract":"Objective. The aim of the present study was to examine the relationship between Toxoplasma gondii and Toxocara spp. infections in patients with schizophrenia disorder. Method. A total of 100 patients with schizophrenia disorder and 95 healthy individuals participated in the study. Participants were tested for the presence of anti-T. gondii and anti-Toxocara spp. antibodies by ELISA and Western blotting. Data were analyzed using Chi-square test and Fisher 9 s exact test. Results. There were no differences in T. gondii IgG seroprevalence between patients with schizophrenia and healthy individuals (P = 0.1), but there were differences in seroprevalence between males and females with schizophrenia (P = 0.009). In contrast, Toxocara spp. IgG seroprevalence was greater in patients with schizophrenia disorder than in healthy individuals (P = 0.02), but there were no differences in seroprevalence between men and women with schizophrenia (P = 0.5). Finally, there were no differences in seroprevalence of T. gondii or Toxocara spp. IgG among different subtypes of schizophrenia, various age groups, residential area, or clinical course of treatment (P > 0.05). Conclusion. The present study suggests that patients with schizophrenia disorder are at elevated risk of Toxocara spp. infection. Moreover, contamination with T. gondii is a risk factor for schizophrenia in women. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"230349"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/230349","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32348016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 42

Long-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approach. 长期利培酮治疗诱导小鼠肝脂肪变性相关内脏脂肪:磁共振方法。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-04-27 DOI: 10.1155/2014/429291

Florent Auger, Patrick Duriez, Françoise Martin-Nizard, Nicolas Durieux, Régis Bordet, Olivier Pétrault

{"title":"Long-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approach.","authors":"Florent Auger, Patrick Duriez, Françoise Martin-Nizard, Nicolas Durieux, Régis Bordet, Olivier Pétrault","doi":"10.1155/2014/429291","DOIUrl":"https://doi.org/10.1155/2014/429291","url":null,"abstract":"Although atypical antipsychotic drugs (APDs) have led to significant advances in the treatment of psychotic disorders, they still induce metabolic disturbances. We aimed at characterizing the metabolic consequences of a risperidone treatment and at establishing a link with noninvasive MR markers, in order to develop a tool for predicting symptoms of the metabolic syndrome. Fat deposition and liver morphometry were assessed by T1-weighted imaging. Fatty acid composition and fat accumulations in tissues were determined using MR spectroscopy with and without water suppression, respectively. Risperidone treatment induced a weight gain accompanied with metabolic disturbances such as hyperglycemic status, an increase in visceral adipose tissue (VAT), and liver fat depositions. Correlations using Methylene-Water Ratio (MWR) and Polyunsaturated Index (PUI) demonstrated a concomitant increase in the weight gain, VAT and liver fat depositions, and a decrease in the quantity of polyunsaturated fatty acids. These results were consistent with a hepatic steatosis state. We evaluated the ability of MR techniques to detect subtle metabolic disorders induced by APDs. Thus, our model and methodology offer the possibility to investigate APDs side effects in order to improve the health conditions of schizophrenic patients. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"429291"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/429291","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32379611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

Eating disorders in schizophrenia: implications for research and management. 精神分裂症的饮食失调:对研究和管理的启示。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-11-18 DOI: 10.1155/2014/791573

Youssef Kouidrat, Ali Amad, Jean-Daniel Lalau, Gwenole Loas

{"title":"Eating disorders in schizophrenia: implications for research and management.","authors":"Youssef Kouidrat, Ali Amad, Jean-Daniel Lalau, Gwenole Loas","doi":"10.1155/2014/791573","DOIUrl":"https://doi.org/10.1155/2014/791573","url":null,"abstract":"Objective. Despite evidence from case series, the comorbidity of eating disorders (EDs) with schizophrenia is poorly understood. This review aimed to assess the epidemiological and clinical characteristics of EDs in schizophrenia patients and to examine whether the management of EDs can be improved. Methods. A qualitative review of the published literature was performed using the following terms: \"schizophrenia\" in association with \"eating disorders,\" \"anorexia nervosa,\" \"bulimia nervosa,\" \"binge eating disorder,\" or \"night eating syndrome.\" Results. According to our literature review, there is a high prevalence of comorbidity between schizophrenia and EDs. EDs may occur together with or independent of psychotic symptoms in these patients. Binge eating disorders and night eating syndromes are frequently found in patients with schizophrenia, with a prevalence of approximately 10%. Anorexia nervosa seems to affect between 1 and 4% of schizophrenia patients. Psychopathological and neurobiological mechanisms, including effects of antipsychotic drugs, should be more extensively explored. Conclusions. The comorbidity of EDs in schizophrenia remains relatively unexplored. The clearest message of this review is the importance of screening for and assessment of comorbid EDs in schizophrenia patients. The management of EDs in schizophrenia requires a multidisciplinary approach to attain maximized health outcomes. For clinical practice, we propose some recommendations regarding patient-centered care. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"791573"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/791573","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32890722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 60

Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone. 黑桫椤果实多酚可降低齐拉西酮诱导的血浆脂质过氧化。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-06-25 DOI: 10.1155/2014/602390

Anna Dietrich-Muszalska, Justyna Kopka, Bogdan Kontek

{"title":"Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.","authors":"Anna Dietrich-Muszalska, Justyna Kopka, Bogdan Kontek","doi":"10.1155/2014/602390","DOIUrl":"https://doi.org/10.1155/2014/602390","url":null,"abstract":"Background. Oxidative stress in schizophrenia may be caused partially by the treatment of patients with antipsychotics. The aim of the study was to establish the effects of polyphenol compounds derived from berries of Aronia melanocarpa (Aronox) on the plasma lipid peroxidation induced by ziprasidone in vitro. Methods. Lipid peroxidation was measured by the level of thiobarbituric acid reactive species (TBARS). The samples of plasma from healthy subjects were incubated with ziprasidone (40 ng/ml; 139 ng/ml; and 250 ng/ml) alone and with Aronox (5 ug/ml; 50 ug/ml). Results. We observed a statistically significant increase of TBARS level after incubation of plasma with ziprasidone (40 ng/ml; 139 ng/ml; and 250 ng/ml) (after 24 h incubation: P = 7.0 × 10(-4), P = 1.6 × 10(-3), and P = 2.7 × 10(-3), resp.) and Aronox lipid peroxidation caused by ziprasidone was significantly reduced. After 24-hour incubation of plasma with ziprasidone (40 ng/ml; 139 ng/ml; and 250 ng/ml) in the presence of 50 ug/ml Aronox, the level of TBARS was significantly decreased: P = 6.5 × 10(-8), P = 7.0 × 10(-6), and P = 3.0 × 10(-5), respectively. Conclusion. Aronox causes a distinct reduction of lipid peroxidation induced by ziprasidone. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"602390"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/602390","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32532894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 10

Gender identity disorder and schizophrenia: neurodevelopmental disorders with common causal mechanisms? 性别认同障碍与精神分裂症:具有共同因果机制的神经发育障碍?

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-12-04 DOI: 10.1155/2014/463757

Ravi Philip Rajkumar

引用次数: 42

Not all distraction is bad: working memory vulnerability to implicit socioemotional distraction correlates with negative symptoms and functional impairment in psychosis. 并非所有的分心都是不好的:工作记忆容易受到内隐社会情绪分心的影响，与精神病的负面症状和功能损害有关。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-02-27 DOI: 10.1155/2014/320948

Quintino R Mano, Gregory G Brown, Heline Mirzakhanian, Khalima Bolden, Kristen S Cadenhead, Gregory A Light

{"title":"Not all distraction is bad: working memory vulnerability to implicit socioemotional distraction correlates with negative symptoms and functional impairment in psychosis.","authors":"Quintino R Mano, Gregory G Brown, Heline Mirzakhanian, Khalima Bolden, Kristen S Cadenhead, Gregory A Light","doi":"10.1155/2014/320948","DOIUrl":"10.1155/2014/320948","url":null,"abstract":"This study investigated implicit socioemotional modulation of working memory (WM) in the context of symptom severity and functional status in individuals with psychosis (N = 21). A delayed match-to-sample task was modified wherein task-irrelevant facial distracters were presented early and briefly during the rehearsal of pseudoword memoranda that varied incrementally in load size (1, 2, or 3 syllables). Facial distracters displayed happy, sad, or emotionally neutral expressions. Implicit socioemotional modulation of WM was indexed by subtracting task accuracy on nonfacial geometrical distraction trials from facial distraction trials. Results indicated that the amount of implicit socioemotional modulation of high WM load accuracy was significantly associated with negative symptoms (r = 0.63, P < 0.01), role functioning (r = -0.50, P < 0.05), social functioning (r = -0.55, P < 0.01), and global assessment of functioning (r = -0.53, P < 0.05). Specifically, greater attentional distraction of high WM load was associated with less severe symptoms and functional impairment. This study demonstrates the importance of the WM-socioemotional interface in influencing clinical and psychosocial functional status in psychosis. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"320948"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/320948","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32255727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison. Pomaglumetad Methionil (LY2140023 Monohydrate)和阿立哌唑在精神分裂症患者中的作用:3期、多中心、双盲比较

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-03-19 DOI: 10.1155/2014/758212

David H Adams, Lu Zhang, Brian A Millen, Bruce J Kinon, Juan-Carlos Gomez

{"title":"Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison.","authors":"David H Adams, Lu Zhang, Brian A Millen, Bruce J Kinon, Juan-Carlos Gomez","doi":"10.1155/2014/758212","DOIUrl":"https://doi.org/10.1155/2014/758212","url":null,"abstract":"We tested the hypothesis that long-term treatment with pomaglumetad methionil would demonstrate significantly less weight gain than aripiprazole in patients with schizophrenia. In this 24-week, multicenter, randomized, double-blind, Phase 3 study, 678 schizophrenia patients were randomized to either pomaglumetad methionil (n = 516) or aripiprazole (n = 162). Treatment groups were also compared on efficacy and various safety measures, including serious adverse events (SAEs), discontinuation due to adverse events (AEs), treatment-emergent adverse events (TEAEs), extrapyramidal symptoms (EPS), and suicide-related thoughts and behaviors. The pomaglumetad methionil group showed significantly greater weight loss at Week 24 (Visit 12) compared with the aripiprazole group (-2.8 ± 0.4 versus 0.4 ± 0.6; P < 0.001). However, change in Positive and Negative Syndrome Scale (PANSS) total scores for aripiprazole was significantly greater than for pomaglumetad methionil (-15.58 ± 1.58 versus -12.03 ± 0.99; P = 0.045). The incidences of SAEs (8.2% versus 3.1%; P = 0.032) and discontinuation due to AEs (16.2% versus 8.7%; P = 0.020) were significantly higher for pomaglumetad methionil compared with aripiprazole. No statistically significant differences in the incidence of TEAEs, EPS, or suicidal ideation or behavior were noted between treatment groups. In conclusion, long-term treatment with pomaglumetad methionil resulted in significantly less weight gain than aripiprazole. This trial is registered with ClinicalTrials.gov NCT01328093. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"758212"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/758212","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32295802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 54

Explaining attitudes and adherence to antipsychotic medication: the development of a process model. 解释对抗精神病药物的态度和依从性:过程模型的发展。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-02-19 DOI: 10.1155/2014/341545

Martin Wiesjahn, Esther Jung, Fabian Lamster, Winfried Rief, Tania M Lincoln

{"title":"Explaining attitudes and adherence to antipsychotic medication: the development of a process model.","authors":"Martin Wiesjahn, Esther Jung, Fabian Lamster, Winfried Rief, Tania M Lincoln","doi":"10.1155/2014/341545","DOIUrl":"https://doi.org/10.1155/2014/341545","url":null,"abstract":"Although nonadherence to antipsychotic medication poses a threat to outcome of medical treatment, the processes preceding the intake behavior have not been investigated sufficiently. This study tests a process model of medication adherence derived from the Health Belief Model which is based on cost-benefit considerations. The model includes an extensive set of potential predictors for medication attitudes and uses these attitudes as a predictor for medication adherence. We conducted an online study of 84 participants with a self-reported psychotic disorder and performed a path analysis. More insight into the need for treatment, a higher attribution of the symptoms to a mental disorder, experience of less negative side effects, presence of biological causal beliefs, and less endorsement of psychological causal beliefs were significant predictors of more positive attitudes towards medication. The results largely supported the postulated process model. Mental health professionals should consider attitudes towards medication and the identified predictors when they address adherence problems with the patient in a shared and informed decision process. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"341545"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/341545","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32230103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 22

Irony and proverb comprehension in schizophrenia: do female patients "dislike" ironic remarks? 精神分裂症患者的讽刺和谚语理解：女性患者 "不喜欢 "讽刺性言论吗？

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-06-03 DOI: 10.1155/2014/841086

Alexander M Rapp, Karin Langohr, Dorothee E Mutschler, Barbara Wild

{"title":"Irony and proverb comprehension in schizophrenia: do female patients \"dislike\" ironic remarks?","authors":"Alexander M Rapp, Karin Langohr, Dorothee E Mutschler, Barbara Wild","doi":"10.1155/2014/841086","DOIUrl":"10.1155/2014/841086","url":null,"abstract":"Difficulties in understanding irony and sarcasm are part of the social cognition deficits in patients with schizophrenia. A number of studies have reported higher error rates during comprehension in patients with schizophrenia. However, the relationships of these impairments to schizotypal personality traits and other language deficits, such as the comprehension of proverbs, are unclear. We investigated irony and proverb comprehension in an all-female sample of 20 schizophrenia patients and 27 matched controls. Subjects indicated if a statement was intended to be ironic, literal, or meaningless and furthermore rated the meanness and funniness of the stimuli and certainty of their decision. Patients made significantly more errors than controls did. Globally, there were no overall differences in the ratings. However, patients rated the subgroup of stimuli with answers given incorrectly as having significantly less meanness and in case of an error indicated a significantly higher certainty than controls. Across all of the study participants, performances in irony (r = -0.51) and proverb (r = 0.56) comprehension were significantly correlated with schizotypal personality traits, suggesting a continuum of nonliteral language understanding. Because irony is so frequent in everyday conversations, this makes irony an especially promising candidate for social cognition training in schizophrenia. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"841086"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32479011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0